All Harvest One Medicinal Products Sold Online to Begin Carrying BLOCKStrain-Verified Seal of Authenticity
VANCOUVER, Feb. 14, 2019 /CNW/ – BLOCKStrain Technology Corp. (TSX:V: DNAX) (OTC: BKKSF) (“BLOCKStrain”), creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, today announced that Harvest One Cannabis Inc. (TSX:V: HVT) (OTCQX: HRVOF) (“Harvest One”), a Canadian licensed producer of medical cannabis, will employ BLOCKStrain’s proprietary genome tracking software to collect and register its cannabis plant DNA and strains.
By incorporating BLOCKStrain’s cannabis strain authenticity and tracking platform – the Master Genome Strain and Clone Registration Program – into its sales program, Harvest One is expected to be able to confirm its medical cannabis strains are as labelled, providing its consumers with increased transparency and confidence about its products. Upon completion of the collection and registration of its strains, an initial 30 Harvest One products will carry BLOCKStrain’s Seal of Authenticity, guaranteeing their origin and providing quality assurance.
“This agreement with Harvest One is a testament to the growing traction of our proprietary genome-to-sale software, which we expect to increase as more companies recognize the inherent and significant value in protecting the genetics and IP of their various strains,” said BLOCKStrain’s Chief Executive Officer, Robert Galarza. “We believe our unique technology will enable Harvest One to guarantee its strains and provide consumers with unparalleled assuredness about the products they purchase. This is of particular importance for medical cannabis when patients with specific conditions are relying on products to be of consistent quality and provide consistent results.”
“BLOCKStrain’s technology is intended to enable us to guarantee that our strain origins and content are exactly as labelled, providing medical consumers with a level of certainty they could not expect with similar, unverified products,” said Grant Froese, Chief Executive Officer of Harvest One. “This increased level of quality control is in keeping with our mission build a global house of brands, providing lifestyle and wellness health products to consumers and patients in regulated markets.”
About BLOCKStrain’s Master Genome Strain & Clone Registration Program:
Under its Master Genome Strain & Clone Registration Program (the “Program”), BLOCKStrain’s team collects plant data and performs genomic sequencing in plant batches which are then registered in a blockchain-enabled database for intellectual property protection and strain validation. BLOCKStrain believes all information gathered from the plants, including their molecular and chemical makeup, can be tracked via the Program. Going forward, it is expected that a quick response (QR) barcode specific to each plant batch will be able to reveal, among other things, how a plant was cloned and cultivated, and its cannabinoid content. A video introducing the WeedMD and BLOCKStrain pilot project, representing the first example of commercial use of the Program, can be found here.
About BLOCKStrain:
BLOCKStrain has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. BLOCKStrain’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. BLOCKStrain’s technology is proprietary, immutable and cryptographically secure, thereby establishing a single-source, accurate, validated, and permanent account for cannabis strains from ownership to market.
About Harvest One:
Harvest One is a global cannabis company that develops and provides innovative lifestyle and wellness products to consumers and patients in regulated markets around the world. Its range of lifestyle solutions is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through three wholly-owned subsidiaries: United Greeneries, a Licensed Producer; Satipharm (medical and nutraceutical); and Dream Water Global (consumer), and a minority interest in Burb Cannabis (retail operations). For more information, please visit www.harvestone.com.
